文献速递复苏、休克与脓毒症

钙剂对无脉性电活动及可能与高钾血症和缺血相关心电图特征患者的影响:COCA试验亚组分析

Effect of calcium in patients with pulseless electrical activity and electrocardiographic characteristics potentially associated with hyperkalemia and ischemia-sub-study of the Calcium for Out-of-hospital Cardiac Arrest (COCA) trial.
PubMed 文献 · Resuscitation · 2022-11-18
一句话结论在无脉性电活动的院外心脏骤停成人中,钙剂较安慰剂自主循环恢复和30天生存均无获益且效应估计提示可能有害,结果不支持仅凭心电图表现使用钙剂。

本文为COCA试验(院外心脏骤停钙剂试验)的预设亚组分析,纳入≥18岁非创伤性院外心脏骤停且接受肾上腺素的患者,试验药为氯化钙5 mmol或生理盐水安慰剂,在首剂及第二剂肾上腺素后各给一次、最多两次。本亚组分析以给予试验药前最后已知心律为无脉性电活动的患者为对象,共104例。钙剂组9例(20%)恢复自主循环 vs 安慰剂组23例(39%)(风险比0.51;95%CI 0.26, 1.00);30天生存钙剂组1例(2.2%)vs 安慰剂组8例(13.6%)(风险比0.16;95%CI 0.02, 1.26)。基于可能与高钾血症和缺血相关心电图特征的亚组分析结果相似。作者认为结果不支持仅根据院外心脏骤停期间的心电图表现给予钙剂。

要点

  • 无脉性电活动院外心脏骤停成人中,钙剂组自主循环恢复9例(20%)vs 安慰剂组23例(39%),风险比0.51(95%CI 0.26, 1.00)。
  • 30天生存钙剂组1例(2.2%)vs 安慰剂组8例(13.6%),风险比0.16(95%CI 0.02, 1.26),置信区间宽。
  • 基于可能与高钾血症和缺血相关心电图特征的亚组分析结果与总体相似。
  • 作者认为结果不支持仅根据院外心脏骤停期间的心电图表现给予钙剂。
  • 试验药为氯化钙5 mmol或生理盐水安慰剂,在首剂及第二剂肾上腺素后给药,最多两次。

适用人群与场景

  • 年龄≥18岁、非创伤性院外心脏骤停且接受肾上腺素的患者。
  • 本亚组分析对象为给予试验药前最后已知心律为无脉性电活动的患者。

处置流程与药物剂量

  • 试验方案:氯化钙5 mmol或生理盐水安慰剂,在首剂肾上腺素后给药,并在第二剂肾上腺素后再次给药,最多两剂。

研究设计与关键结果

  • 研究类型:COCA试验的预设亚组分析,共分析104例无脉性电活动患者。
  • 干预与对照:氯化钙5 mmol vs 生理盐水安慰剂,在首剂及第二剂肾上腺素后给药,最多两剂。
  • 主要结局:恢复自主循环钙剂组9例(20%)vs 安慰剂组23例(39%),风险比0.51(95%CI 0.26, 1.00)。
  • 30天生存:钙剂组1例(2.2%)vs 安慰剂组8例(13.6%),风险比0.16(95%CI 0.02, 1.26)。
  • 基于可能与高钾血症和缺血相关心电图特征的亚组分析结果相似。

证据类型、等级与局限

  • 证据类型:随机对照试验(COCA试验)的预设亚组分析。
  • 局限:原文未报告局限性。

对床旁实践的改变

  • 作者认为,结果不支持仅根据院外心脏骤停期间的心电图表现给予钙剂。

提炼说明

  • 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开

OBJECTIVE: The Calcium for Out-of-hospital Cardiac Arrest (COCA) trial was recently conducted and published. This pre-planned sub-study evaluated the effect of calcium in patients with pulseless electrical activity (PEA) including subgroup analyses based on electrocardiographic characteristics potentially associated with hyperkalemia and ischemia.

METHODS: Patients aged ≥ 18 years were included if they had a non-traumatic out-of-hospital cardiac arrest and received adrenaline. The trial drug consisted of calcium chloride (5 mmol) or saline placebo given after the first, and again after the second, dose of adrenaline for a maximum of two doses. This sub-study analyzed patients with PEA as their last known rhythm prior to receiving the trial drug. Outcomes were return of spontaneous circulation and survival at 30 days.

RESULTS: 104 patients were analyzed. In the calcium group, 9 patients (20 %) achieved return of spontaneous circulation vs 23 patients (39 %) in the placebo group (risk ratio 0.51; 95 %CI 0.26, 1.00). Subgroup analyses based on electrocardiographic characteristics potentially associated with hyperkalemia and ischemia showed similar results. At 30 days, 1 patient (2.2 %) was alive in the calcium group while 8 patients (13.6 %) were alive in the placebo group (risk ratio 0.16; 95 %CI 0.02, 1.26).

CONCLUSION: In adults with out-of-hospital cardiac arrest presenting with PEA, effect estimates suggested harm of calcium administration as compared to placebo but with wide confidence intervals. Results were consistent for patients with electrocardiographic characteristics potentially associated with hyperkalemia and ischemia. The results do not support calcium administration based strictly on electrocardiographic findings seen during out-of-hospital cardiac arrest.

来源:Resuscitation,查看原文。版权归原作者所有。

参考来源

  1. Vallentin MF, Povlsen AL, Granfeldt A, et al. Effect of calcium in patients with pulseless electrical activity and electrocardiographic characteristics potentially associated with hyperkalemia and ischemia-sub-study of the Calcium for Out-of-hospital Cardiac Arrest (COCA) trial. Resuscitation. 2022. PMID: 36403820. doi:10.1016/j.resuscitation.2022.11.006

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。